Karyopharm Therapeutics Inc.
USD10.14
+0.06 (+0.55%)
CEO
Richard A. Paulson
IPO Date
2013-11-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$10.11
Prev. Close
$10.09
Day Low
$9.81
Day High
$10.14
52W Low
$3.65
52W High
$10.99
Market Cap
$0.23B
Volume
0.05M
| -1.1 |
| 31 Dec 2023 | FY | 96.6% | -98.0% | 105.1% | -59.5% | -1.30 | 3.37 | -0.7 |
| 31 Dec 2022 | FY | 96.7% | -105.2% | 992.4% | -46.1% | -10.75 | 5.31 | -1.7 |
| 31 Dec 2021 | FY | 98.4% | -59.1% | 155.7% | -40.6% | -2.27 | 3.74 | -3.9 |
| 31 Dec 2020 | FY | 97.5% | -181.6% | -388.3% | -62.7% | 2.59 | 4.59 | -5.7 |
| 31 Dec 2019 | FY | 94.1% | -488.1% | -401.0% | -67.7% | 2.51 | 6.01 | -5.9 |
| 31 Dec 2018 | FY | -431.9% | -588.1% | -97.4% | -52.3% | 0.56 | 7.13 | -3.0 |
| 31 Dec 2017 | FY | -6583.7% | -8036.4% | -99.6% | -71.5% | 0.00 | 3.00 | -3.4 |
| 31 Dec 2016 | FY | -56353.2% | -71153.9% | -67.5% | -60.7% | 0.00 | 7.99 | -3.2 |
| -0.3 |
| 30 Sept 2025 | Q3 | 95.2% | -75.2% | 12.3% | -34.4% | -0.73 | 1.03 | -0.4 |
| 30 Jun 2025 | Q2 | 97.2% | -98.2% | 15.6% | -35.5% | -0.80 | 0.99 | -0.2 |
| 31 Mar 2025 | Q1 | 95.7% | -78.2% | 11.4% | -18.4% | -0.91 | 1.33 | -0.3 |
| 31 Dec 2024 | Q4 | 95.6% | -100.8% | 16.5% | -18.7% | -1.05 | 1.70 | -0.7 |
| 30 Sept 2024 | Q3 | 96.6% | -82.7% | 20.1% | -16.9% | -1.22 | 3.00 | -0.8 |
| 30 Jun 2024 | Q2 | 96.4% | 55.6% | -18.0% | 11.1% | -1.48 | 3.62 | 1.0 |
| 31 Mar 2024 | Q1 | 94.0% | -112.8% | 22.1% | -18.3% | -1.04 | 3.04 | -1.2 |
| 31 Dec 2023 | Q4 | 95.4% | -124.0% | 30.7% | -17.4% | -1.30 | 3.37 | -0.6 |